Form 4: Day One Biopharmaceuticals Director Saira Ramasastry Sells 10,000 Shares
SEC Form 4 Filing
Director Saira Ramasastry sold 10,000 shares of Day One Biopharmaceuticals, Inc. (DAWN) at an average price of $13.1877 on June 21, 2024.
Summary
- On June 21, 2024, Saira Ramasastry, a director of Day One Biopharmaceuticals, Inc. (DAWN), sold 10,000 shares of common stock.
- The sale was executed at a weighted average price of $13.1877 per share.
- The prices for individual transactions ranged from $12.91 to $13.545 per share.
- Following the transaction, Ramasastry directly owns 40,485 shares of Day One Biopharmaceuticals.
Sentiment
Score: 5
Explanation: The sentiment is neutral. It's a routine disclosure of a stock sale by a director. The impact on investor sentiment depends on individual interpretation and broader market conditions.
Negatives
- A director selling shares could be perceived negatively by investors, although the reason for the sale is not disclosed.
Risks
- The sale of shares by a director could potentially signal a lack of confidence in the company's future performance, although this is not explicitly stated.
Industry Context
Sales by company insiders are a common occurrence and are publicly disclosed to maintain transparency in the market. Investors often monitor these transactions to gauge insider sentiment about the company's prospects.
Comparison to Industry Standards
- Insider sales are a normal part of corporate governance, and the impact on the stock price often depends on the size of the sale relative to the insider's holdings and the overall market sentiment.
- Comparable companies in the biopharmaceutical sector also experience insider trading activity, which is closely watched by investors.
- The sale by Ramasastry is relatively small compared to the overall market capitalization of Day One Biopharmaceuticals.
Stakeholder Impact
- Shareholders may react to the news of the director's stock sale, potentially leading to short-term price fluctuations.
- The impact on other stakeholders (employees, customers, etc.) is likely minimal, as this is a standard financial transaction.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of the transaction: Saira Ramasastry sold 10,000 shares of Day One Biopharmaceuticals. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.